Soft Landing Labs Completes Going Public Transaction
Soft Landing Labs, LTD (OTCQB: SLNZ), announced its common stock is approved for quotation on the OTC Markets’ OTC Pink Sheets marketplace under the ticker symbol “SLNZ” and its shares are eligible for electronic trading through Depository Trust Company (“DTC”).
Shareholders of SLNZ are able to view the real-time Level II stock quotes for the Company’s common stock at http://www.otcmarkets.com/stock/SLNZ/quote
Dr. Abdel Fahmy, Chief Executive Officer of SLNZ stated, “We are very pleased to have completed our going public transaction by being quoted on the OTCMarkets OTC Pink Sheets as the first step to creating liquidity, particularly for our current and future shareholders.”
About Soft Landing Labs, LTD
SLNZ was founded in 2009, to provide specialized laboratory testing focused on small molecules and toxicology including drug testing using highly sensitive technology. For the nine month period ending September 30, 2013, SLNZ’s revenues were $2,219,751
Company Contact:
Soft Landing Labs
747 Church Rd Ste F4
Elmhurst, IL 60126
Tel: 630-758-0030
Fax: 630-758-0040
Legal Contact:
Hamilton & Associates Securities Lawyers
Brenda Hamilton, Securities Attorney
101 Plaza Real South, Suite 202 N
Boca Raton, Florida 33432
Telephone: (561) 416-8956
Facsimile: (561) 416-2855
www.SecuritiesLawyer101.com
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release includes various “forward-looking statements” which represent the Company’s expectations or beliefs concerning future events. Statements containing expressions such as “believes,” “anticipates,” “intends,” or “expects,” used in the Company’s press releases and in Disclosure Statements and Reports filed through the OTC Disclosure and News Service are intended to identify forward-looking statements. All forward-looking statements involve risks and uncertainties. Although the Company believes its expectations are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, there can be no assurances that actual results will not differ materially from expected results. The Company cautions that these and similar statements included in this report are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date thereof. The Company undertakes no obligation to publicly release any revisions to such forward-looking statements to reflect events or circumstances after the date hereof.
For further information about this securities law blog post, please contact Brenda Hamilton, Securities Attorney at 101 Plaza Real S, Suite 202 N, Boca Raton, Florida, (561) 416-8956, by email at [email protected] or visit www.securitieslawyer101.com. This securities law blog post is provided as a general informational service to clients and friends of Hamilton & Associates Law Group and should not be construed as, and does not constitute, legal and compliance advice on any specific matter, nor does this message create an attorney-client relationship. Please note that the prior results discussed herein do not guarantee similar outcomes.
Hamilton & Associates | Securities Lawyers
Brenda Hamilton, Securities Attorney
101 Plaza Real South, Suite 202 North
Boca Raton, Florida 33432
Telephone: (561) 416-8956
Facsimile: (561) 416-2855
www.SecuritiesLawyer101.com
